We are live on ! Find out more
ANGO icon

AngioDynamics

116 hedge funds and large institutions have $413M invested in AngioDynamics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more call options, than puts

Call options by funds: $1.23M | Put options by funds: $398K

46% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 39

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

9% less capital invested

Capital invested by funds: $454M → $413M (-$40.7M)

12% less funds holding

Funds holding: 132116 (-16)

75% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 20

Holders
116
Holders Change
-16
Holders Change %
-12.12%
% of All Funds
3.13%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
5
Increased
57
Reduced
39
Closed
20
Calls
$1.23M
Puts
$398K
Net Calls
+$832K
Net Calls Change
-$160K

ANGO Hedge Fund Activity: Q2 2015 in Review

116 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2015, worth a combined $413M — down 9% from $454M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ANGO and 5 opened new positions — a net loss of 15 holders — while 39 trimmed existing stakes and 57 added.

The largest buyer was RGM Capital, adding an estimated $6.56M. The largest seller was THB Asset Management, exiting entirely with an estimated $7.88M sold.

  • 116 institutional investors held AngioDynamics (ANGO) as of Q2 2015, down from 132 in Q1 2015.
  • Funds reported $413M of AngioDynamics stock for Q2 2015, down 9% quarter-over-quarter.
  • 5 funds opened new AngioDynamics positions in Q2 2015 and 20 closed out, a net change of -15 holders.
  • The largest AngioDynamics buyer in Q2 2015 was RGM Capital, an estimated $6.56M added.
  • The largest AngioDynamics seller in Q2 2015 was THB Asset Management, an estimated $7.88M sold.

Based on aggregated 13F filings for Q2 2015.